Status:
COMPLETED
Crystallized Phenol Treatment in Pilonidal Sinus
Lead Sponsor:
Gulhane Training and Research Hospital
Conditions:
Pilonidal Sinus of Natal Cleft
Pilonidal Sinus Without Abscess
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Pilonidal sinus disease is an acquired disorder of the natal cleft and its incidence is reported as 6 in 100,000. Although there are many opinions regarding the treatment of pilonidal sinus disease in...
Detailed Description
Pilonidal sinus disease is an acquired disorder of the natal cleft and its incidence is reported as 6 in 100,000. Although there are many opinions regarding the treatment of pilonidal sinus disease in...
Eligibility Criteria
Inclusion
- Patients with symptoms due to chronic primary or recurring pilonidal sinus disease interfering with daily life
- Patients giving written informed consent
- Patients who can be contacted by e-mail or telephone
- Patients aged 18 years and older
Exclusion
- Patients with no or minimal symptoms related to pilonidal sinus disease
- Patients with an acute pilonidal abscess or complex, multiple recurrent pilonidal diseases
- Patients who could not be contacted during the follow-up period.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04681443
Start Date
January 1 2018
End Date
December 31 2021
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gulhane Training and Research Hospital
Ankara, Turkey (Türkiye), 06010